Authors' Reply to Ravi Jandhyala's Comment on "Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulatory Assessments"
dc.contributor.author | McGettigan, P | |
dc.contributor.author | Olmo, CA | |
dc.contributor.author | Plueschke, K | |
dc.contributor.author | Castillon, M | |
dc.contributor.author | Zondag, D | |
dc.contributor.author | Bahri, P | |
dc.contributor.author | Kurz, X | |
dc.contributor.author | Mol, PGM | |
dc.date.accessioned | 2021-01-12T15:35:14Z | |
dc.date.available | 2021-01-12T15:35:14Z | |
dc.date.issued | 2019-12 | |
dc.identifier.issn | 0114-5916 | |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/69640 | |
dc.format.extent | 1517 - 1518 | |
dc.relation.ispartof | DRUG SAFETY | |
dc.title | Authors' Reply to Ravi Jandhyala's Comment on "Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulatory Assessments" | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1007/s40264-019-00863-w | |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000496663800011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 12 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 42 | en_US |